<DOC>
	<DOC>NCT00967642</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant defense) and inflammation (C-reactive protein (CRP) and sCD40L) in diabetic patients submitted to PCI with stent.</brief_summary>
	<brief_title>Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients with Diabetes Mellitus submitted to Percutaneous Coronary Intervention with Stent bare metal Age: 1880 years old Restenosis Drug elution stent Acute coronary syndrome at last 30 days Use anti inflammatory, antibiotic, vitamin E Inflammatory disease or oncologic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent</keyword>
</DOC>